ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PALI Palisade Bio Inc

1.76
-0.04 (-2.22%)
After Hours
Last Updated: 22:30:10
Delayed by 15 minutes
Share Name Share Symbol Market Type
Palisade Bio Inc NASDAQ:PALI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.04 -2.22% 1.76 1.75 1.83 1.86 1.75 1.79 120,797 22:30:10

Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

08/10/2024 1:00pm

GlobeNewswire Inc.


Palisade Bio (NASDAQ:PALI)
Historical Stock Chart


From Sep 2024 to Dec 2024

Click Here for more Palisade Bio Charts.

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, CMO of Palisade Bio will participate in a fireside chat at the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on Tuesday, October 15, 2024 at 4:30 PM ET.

Maxim Senior Analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. We also plan to host several topical industry panels that promise to be timely and engaging. To attend, just sign up to become an M-Vest member and stay tuned for more updates.

Click here to reserve your seat

About Palisade Bio Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations Contact

JTC Team, LLCJenene Thomas 908-824-0775PALI@jtcir.com

1 Year Palisade Bio Chart

1 Year Palisade Bio Chart

1 Month Palisade Bio Chart

1 Month Palisade Bio Chart